Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: J Pediatr. 2020 Jan 31;219:152–159.e5. doi: 10.1016/j.jpeds.2019.12.028

Table III.

Outcomes at 22–26 months’ corrected age by BPD grade.

Variable
No BPD (N=1,208) Any BPD (N=1,102) P-valueA Grade 1 (N=806) Grade 2 (N=177) Grade 3 (N=119) P-valueA
Corrected age (months), mean (SD) 24.4 (2.8) 24.6 (2.7) 0.128 24.5 (2.6) 24.8 (3.3) 24.4 (2.2) .176
Bayley-III composite, mean (SD)B
Cognitive 89.1 (14.2) 83.0 (16.2) <0.001^ 85.5 (15.4) 79.5 (16.3) 71.0 (15.5) <.001*§ǂ
Language 85.5 (16.4) 78.7 (17.5) <0.001^ 81.2 (17.0) 74.6 (17.1) 67.1 (16.6) <.001*§ǂ
Motor 89.4 (15.1) 80.8 (17.2) <0.001^ 83.6 (15.6) 76.9 (18.2) 68.0 (19.0) <.001*§ǂ
CBCL syndrome scales, mean (SD)
Aggressive Behavior 55.1 (8.1) 54.4 (7.3) 0.050^ 54.8 (7.6) 53.6 (5.8) 53.5 (7.2) .023
Anxious/Depressed 53.5 (5.6) 53.5 (5.5) 0.896 53.7 (5.7) 53.1 (5.1) 52.8 (4.7) .332
Attention Problems 56.9 (8.0) 57.5 (8.1) 0.067 57.6 (8.3) 56.8 (7.7) 57.3 (7.1) .189
Emotionally Reactive 54.1 (6.5) 54.2 (6.7) 0.747 54.4 (6.9) 53.7 (5.9) 53.7 (6.5) .454
Sleep Problems 54.8 (7.8) 54.1 (7.5) 0.024^ 54.5 (7.6) 53.1 (6.4) 52.9 (6.9) .008
Somatic Complaints 53.6 (5.7) 54.2 (6.3) 0.025^ 54.0 (6.4) 54.3 (5.8) 55.0 (6.0) .055
Withdrawn 55.8 (7.5) 56.9 (8.4) <0.001^ 56.6 (8.4) 57.5 (8.4) 58.5 (8.8) <.001
CBCL DSM-oriented scales, mean (SD)
Affective Problems 54.6 (6.4) 54.7 (6.4) 0.619 54.8 (6.7) 54.7 (5.8) 54.1 (5.2) .656
Anxiety Problems 54.1 (6.4) 53.9 (6.5) 0.583 54.2 (6.7) 53.4 (6.1) 53.3 (5.5) .320
Attention Deficit/Hyperactivity Problems 56.2 (7.3) 56.1 (7.2) 0.752 56.4 (7.4) 55.5 (6.8) 55.4 (5.8) .289
Oppositional Defiant Problems 54.7 (7.1) 54.4 (6.8) 0.374 54.7 (6.9) 53.7 (6.2) 53.7 (6.2) .150
Pervasive Developmental Problems 56.2 (7.9) 57.5 (8.5) <0.001^ 57.3 (8.7) 57.4 (7.9) 59.0 (8.2) <.001*
CBCL problem scores, mean (SD)
Externalizing Problems 51.1 (11.9) 50.6 (11.5) 0.247 51.1 (11.7) 49.1 (10.8) 49.1 (10.7) .051
Internalizing Problems 49.2 (11.0) 49.9 (11.3) 0.094 49.8 (11.5) 49.9 (10.8) 51.3 (9.8) .179
Total Problems 51.0 (11.7) 51.1 (11.5) 0.882 51.4 (11.9) 50.1 (10.9) 50.8 (10.0) .598
Neurosensory outcomes, N (%)
Cerebral palsy 149 (12.4) 232 (21.2) <0.001^ 139 (17.3) 43 (24.9) 50 (42.0) <.001*§ǂ
Hearing impairment 24 (2.0) 38 (3.5) 0.028^ 24 (3.0) 8 (4.7) 6 (5.1) .059
Bilateral blindness 9 (0.7) 21 (1.9) 0.014^ 9 (1.1) 5 (2.9) 7 (5.9) <.001
Pulmonary outcomes, N (%)
Current supplemental oxygen use 12 (1.0) 115 (10.5) <0.001^ 41 (5.1) 36 (20.5) 38 (31.9) <.001*§ǂ
Current ventilator or CPAP use 4 (0.3) 34 (3.1) <0.001^ 6 (0.7) 8 (4.6) 20 (16.8) <.001§ǂ
Current tracheostomy 1 (0.1) 75 (7) <0.001^ 7 (0.9) 15 (8.5) 53 (44.5) <.001*§ǂ
A

Statistically significant differences at p<0.05 after adjustment for multiple comparisons:

^

No BPD vs. Any BPD;

*

No BPD vs. Grade 1;

No BPD vs. Grade 2;

No BPD vs. Grade 3;

§

Grade 1 vs. Grade 2;

Grade 1 vs. Grade 3;

ǂ

Grade 2 vs. Grade 3.

B

Bayley-III composite scores were available for a subset of children for whom the CBCL was completed: N=1151 children with no BPD, N=773 children with grade 1 BPD, N=169 children with grade 2 BPD, and N=110 children with grade 3 BPD.